Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
Cardiovascular Diabetology|November 26, 2020
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysisGilles R Dagenais, Lars Rydén, Lawrence A Leiter, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2022
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND TrialTali Cukierman-Yaffe, Hertzel C Gerstein, Jan Basile, et al.
The Lancet. Neurology|June 21, 2020
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trialTali Cukierman-Yaffe, Hertzel C Gerstein, Helen M Colhoun, et al.
The Lancet. Diabetes & Endocrinology|January 12, 2020
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trialHertzel C Gerstein, Robert Hart, Helen M Colhoun, et al.
Diabetes, Obesity & Metabolism|June 3, 2017
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutideHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Nature|December 24, 2010
Comprehensive analysis of the chromatin landscape in Drosophila melanogasterPeter V Kharchenko, Artyom A Alekseyenko, Yuri B Schwartz, et al.
Nature Structural & Molecular Biology|December 7, 2010
An assessment of histone-modification antibody qualityThea A Egelhofer, Aki Minoda, Sarit Klugman, et al.
Lancet (London, England)|June 14, 2019
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Lancet (London, England)|June 14, 2019
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trialHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Cell Systems|April 20, 2023
Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversationFrederick R Adler, Alexander R A Anderson, Abhinav Bhushan, et al.
Pageof 30